drugs that target glp 1 GLP-1 Agonists: A Comprehensive Overview Everyone's talking about weight loss

The most frequently investigated GLP-1 RAs were liraglutide and semaglutide, predominantly administered via the subcutaneous route

Unlike other DPP-4 inhibitors, linagliptin is renally excreted very little and is not significantly eliminated by the kidneys

In terms of key secondary outcomes, mean changes from baseline in body weight at week 26 were -1.2 kg, -2.2 kg, and -3.1 kg for semaglutide 3 mg, 7 mg, and 14 mg, respectively

Manufacturing Complexity Drives GLP-1 Drug Prices Up GLP-1 medications are synthetic peptidessmall protein chains that must be manufactured in sterile, highly controlled environments

288 (2), R384R388 (2005)

If you are considering any GLP-1 medications, it looks like semaglutide is likely the best option with the research we have but its important to still approach this with caution